| Genomic Medicine |
1 |
1 |
| Leukemia |
0 |
0.86 |
| Cardiovascular Risk Management |
0 |
0.74 |
| Cancer |
0 |
0.6 |
| Colorectal Cancer |
0 |
0.56 |
| Blood |
0 |
0.49 |
| Heart Failure (HF) |
0 |
0.49 |
| Hereditary Nonpolyposis Colorectal Cancer (HNPCC) |
0 |
0.48 |
| Coronary Artery Disease (CAD) |
0 |
0.38 |
| Renal Failure |
0 |
0.3 |
| Cardiovascular disease |
0 |
0.27 |
| Acute Heart Failure (HF) |
0 |
0.26 |
| Acute Kidney Injury |
0 |
0.26 |
| Genetic Testing |
0 |
0.23 |
| Heart |
0 |
0.22 |
| Cardiovascular Imaging |
0 |
0.21 |
| Cerebrovascular Accident |
0 |
0.2 |
| Decompensated Heart Failure |
0 |
0.19 |
| Thromboembolism |
0 |
0.17 |
| Genetics |
0 |
0.16 |
| Prognosis |
0 |
0.16 |
| Myelodysplastic Syndrome |
0 |
0.15 |
| Acute Leukemia |
0 |
0.14 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Myocardial Infarction (MI) |
0 |
0.13 |
| Acute Myeloid Leukemia |
0 |
0.12 |
| Chemotherapy |
0 |
0.11 |
| Face |
0 |
0.11 |
| Infarction |
0 |
0.11 |
| Kidney |
0 |
0.11 |
| Somatic |
0 |
0.11 |
| Tissue |
0 |
0.11 |
| Cardiogenic Shock |
0 |
0.08 |
| Lipids Management |
0 |
0.06 |
| Stem Cell Research and Therapy |
0 |
0.06 |
| Wound Management |
0 |
0.06 |